Skip to content

Assessment of cardiac involvements in rheumatoid arthritis using a cardiac magnetic resonance approach: multicenter prospective study

Assessment of cardiac involvements in rheumatoid arthritis using a cardiac magnetic resonance approach: multicenter prospective study - Assessment of cardiac involvements in rheumatoid arthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000030703
Enrollment
40
Registered
2018-01-12
Start date
2018-01-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rheumatoid arthritis(RA)

Interventions

None listed

Sponsors

Nihon University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)All rheumatic disease patients were over twenty years old and met the American College of Rheumatology criteria. 2)Cardiac symptoms were absent in all subjects.

Exclusion criteria

Exclusion criteria: Participants were excluded if they had prior self-reported, physician-diagnosed cardiovascular events or procedures, such as myocardial infarction, angioplasty, and CHF. Additional exclusions were diabetes (HbA1c>6.1), hypertension ((systolic blood pressure (BP) >140 mm Hg and/or diastolic BP>90 mm Hg), and dyslipidemia (LDL cholesterol levels >140 mg/dL, an HDL cholesterol level<40 mg/dL, or a triglyceride level>150 mg/dL).History of bronchoconstriction, contraindication to MRI, hypersensivity to gadolinium were absent in all subjects, and others in which the physician deemed inappropriate to enter the study.

Design outcomes

Primary

MeasureTime frame
We explored the associations of cardiac MRI abnormalities with RA disease activity and severity measures.

Secondary

MeasureTime frame
We evaluate to detect the influence of Biologics in cardiac function

Countries

Japan

Contacts

Public ContactHitomi Kobayashi

Nihon University School of Medicine Division of Hematology and Rheumatology

pero1995@gmail.com0339728111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026